Rosalind Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.44M Buy
+1,100,000
New +$2.85M 0.78% 23

Other funds holding ABOS

Rosalind Advisors's ABOS Position: Q3 2026 in Review

Rosalind Advisors opened a new position in Acumen Pharmaceuticals (ABOS) in Q3 2026: 1,100,000 shares worth $2.44M. The stake represents 0.78% of the portfolio and ranks #23 among its holdings.

91 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.

  • Rosalind Advisors held 1,100,000 shares of Acumen Pharmaceuticals worth $2.44M as of Q3 2026.
  • Acumen Pharmaceuticals was a new Rosalind Advisors position in Q3 2026.
  • Acumen Pharmaceuticals made up 0.78% of Rosalind Advisors's portfolio in Q3 2026, its #23 holding.
  • 91 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.

Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.